As shown in Table 1, downregulation of SOX30 was significantly related to advanced tumor, node, and metastasis (TNM) stages (P = 0.019, Table 1), but not to age, sex, tumor size, clinical grade, or pathological type. The gene discussed is SOX30; the disease is neoplasm.